25 XP   0   0   10

Astec LifeSciences Limited
Buy, Hold or Sell?

Let's analyse Astec LifeSciences Limited together

PenkeI guess you are interested in Astec LifeSciences Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Astec LifeSciences Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Astec LifeSciences Limited

I send you an email if I find something interesting about Astec LifeSciences Limited.

Quick analysis of Astec LifeSciences Limited (30 sec.)










What can you expect buying and holding a share of Astec LifeSciences Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.07
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR213.96
Expected worth in 1 year
INR260.66
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
INR52.70
Return On Investment
4.2%

For what price can you sell your share?

Current Price per Share
INR1,243.75
Expected price per share
INR1,042 - INR1,303
How sure are you?
50%

1. Valuation of Astec LifeSciences Limited (5 min.)




Live pricePrice per Share (EOD)

INR1,243.75

Intrinsic Value Per Share

INR-1,333.78 - INR-149.84

Total Value Per Share

INR-1,119.82 - INR64.12

2. Growth of Astec LifeSciences Limited (5 min.)




Is Astec LifeSciences Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$50.3m$47.5m$2.7m5.5%

How much money is Astec LifeSciences Limited making?

Current yearPrevious yearGrowGrow %
Making money$3m$10.7m-$7.7m-251.5%
Net Profit Margin4.1%13.3%--

How much money comes from the company's main activities?

3. Financial Health of Astec LifeSciences Limited (5 min.)




4. Comparing to competitors in the Agricultural Inputs industry (5 min.)




  Industry Rankings (Agricultural Inputs)  


Richest
#115 / 157

Most Revenue
#103 / 157

Most Profit
#99 / 157

What can you expect buying and holding a share of Astec LifeSciences Limited? (5 min.)

Welcome investor! Astec LifeSciences Limited's management wants to use your money to grow the business. In return you get a share of Astec LifeSciences Limited.

What can you expect buying and holding a share of Astec LifeSciences Limited?

First you should know what it really means to hold a share of Astec LifeSciences Limited. And how you can make/lose money.

Speculation

The Price per Share of Astec LifeSciences Limited is INR1,244. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Astec LifeSciences Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Astec LifeSciences Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR213.96. Based on the TTM, the Book Value Change Per Share is INR11.68 per quarter. Based on the YOY, the Book Value Change Per Share is INR44.54 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR1.50 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Astec LifeSciences Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.160.0%0.160.0%0.550.0%0.320.0%0.210.0%
Usd Book Value Change Per Share0.140.0%0.140.0%0.530.0%0.310.0%0.190.0%
Usd Dividend Per Share0.020.0%0.020.0%0.020.0%0.020.0%0.020.0%
Usd Total Gains Per Share0.160.0%0.160.0%0.550.0%0.320.0%0.210.0%
Usd Price Per Share16.62-16.62-21.06-12.17-7.96-
Price to Earnings Ratio106.23-106.23-38.30-44.07-42.09-
Price-to-Total Gains Ratio105.11-105.11-38.13-43.67-29.40-
Price to Book Ratio6.47-6.47-8.68-5.96-5.12-
Price-to-Total Gains Ratio105.11-105.11-38.13-43.67-29.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share14.925
Number of shares67
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.140.31
Usd Total Gains Per Share0.160.32
Gains per Quarter (67 shares)10.5921.77
Gains per Year (67 shares)42.3787.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15383258277
210757410164164
31411311616246251
41915015821328338
52418820026409425
62922524231491512
73426328436573599
83930032642655686
94333836847737773
104837641052819860

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%15.01.00.093.8%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.01.093.8%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%15.01.00.093.8%

Fundamentals of Astec LifeSciences Limited

About Astec LifeSciences Limited

Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemical active ingredients and pharmaceutical intermediates in India. Its products include triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic, aliphatic, and heterocyclic intermediates; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; heterocyclic mercaptans, thiopyrimidines, and aromatic mercaptans; heterocyclic sulfonyl chlorides, sulphonamides, and carbamates; thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.

Fundamental data was last updated by Penke on 2024-04-19 08:01:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Astec LifeSciences Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Astec LifeSciences Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Astec LifeSciences Limited to the Agricultural Inputs industry mean.
  • A Net Profit Margin of 4.1% means that ₹0.04 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Astec LifeSciences Limited:

  • The MRQ is 4.1%. The company is making a profit. +1
  • The TTM is 4.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.1%TTM4.1%0.0%
TTM4.1%YOY13.3%-9.2%
TTM4.1%5Y9.3%-5.2%
5Y9.3%10Y6.5%+2.8%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1%4.9%-0.8%
TTM4.1%5.3%-1.2%
YOY13.3%7.9%+5.4%
5Y9.3%5.4%+3.9%
10Y6.5%3.9%+2.6%
1.1.2. Return on Assets

Shows how efficient Astec LifeSciences Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Astec LifeSciences Limited to the Agricultural Inputs industry mean.
  • 2.6% Return on Assets means that Astec LifeSciences Limited generated ₹0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Astec LifeSciences Limited:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.6%0.0%
TTM2.6%YOY10.0%-7.4%
TTM2.6%5Y7.7%-5.0%
5Y7.7%10Y5.4%+2.2%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6%3.1%-0.5%
TTM2.6%3.0%-0.4%
YOY10.0%3.5%+6.5%
5Y7.7%1.8%+5.9%
10Y5.4%1.5%+3.9%
1.1.3. Return on Equity

Shows how efficient Astec LifeSciences Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Astec LifeSciences Limited to the Agricultural Inputs industry mean.
  • 6.1% Return on Equity means Astec LifeSciences Limited generated ₹0.06 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Astec LifeSciences Limited:

  • The MRQ is 6.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.1%TTM6.1%0.0%
TTM6.1%YOY22.7%-16.6%
TTM6.1%5Y17.3%-11.2%
5Y17.3%10Y12.3%+5.0%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1%5.7%+0.4%
TTM6.1%5.5%+0.6%
YOY22.7%7.6%+15.1%
5Y17.3%4.8%+12.5%
10Y12.3%3.9%+8.4%

1.2. Operating Efficiency of Astec LifeSciences Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Astec LifeSciences Limited is operating .

  • Measures how much profit Astec LifeSciences Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Astec LifeSciences Limited to the Agricultural Inputs industry mean.
  • An Operating Margin of 8.9% means the company generated ₹0.09  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Astec LifeSciences Limited:

  • The MRQ is 8.9%. The company is operating less efficient.
  • The TTM is 8.9%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ8.9%TTM8.9%0.0%
TTM8.9%YOY19.0%-10.1%
TTM8.9%5Y15.1%-6.2%
5Y15.1%10Y12.2%+2.9%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9%9.2%-0.3%
TTM8.9%7.4%+1.5%
YOY19.0%10.7%+8.3%
5Y15.1%8.2%+6.9%
10Y12.2%6.5%+5.7%
1.2.2. Operating Ratio

Measures how efficient Astec LifeSciences Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Agricultural Inputs industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are ₹0.93 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Astec LifeSciences Limited:

  • The MRQ is 0.932. The company is less efficient in keeping operating costs low.
  • The TTM is 0.932. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.932TTM0.9320.000
TTM0.932YOY0.822+0.110
TTM0.9325Y0.860+0.072
5Y0.86010Y0.867-0.006
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9321.564-0.632
TTM0.9321.589-0.657
YOY0.8221.446-0.624
5Y0.8601.564-0.704
10Y0.8671.314-0.447

1.3. Liquidity of Astec LifeSciences Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Astec LifeSciences Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Agricultural Inputs industry mean).
  • A Current Ratio of 0.95 means the company has ₹0.95 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Astec LifeSciences Limited:

  • The MRQ is 0.948. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.948. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.948TTM0.9480.000
TTM0.948YOY1.051-0.103
TTM0.9485Y1.013-0.065
5Y1.01310Y1.027-0.014
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9481.609-0.661
TTM0.9481.628-0.680
YOY1.0511.688-0.637
5Y1.0131.763-0.750
10Y1.0271.637-0.610
1.3.2. Quick Ratio

Measures if Astec LifeSciences Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Astec LifeSciences Limited to the Agricultural Inputs industry mean.
  • A Quick Ratio of 0.30 means the company can pay off ₹0.30 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Astec LifeSciences Limited:

  • The MRQ is 0.304. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.304. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.304TTM0.3040.000
TTM0.304YOY0.676-0.372
TTM0.3045Y0.595-0.291
5Y0.59510Y0.567+0.028
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3040.535-0.231
TTM0.3040.621-0.317
YOY0.6760.684-0.008
5Y0.5950.757-0.162
10Y0.5670.803-0.236

1.4. Solvency of Astec LifeSciences Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Astec LifeSciences Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Astec LifeSciences Limited to Agricultural Inputs industry mean.
  • A Debt to Asset Ratio of 0.57 means that Astec LifeSciences Limited assets are financed with 57.2% credit (debt) and the remaining percentage (100% - 57.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Astec LifeSciences Limited:

  • The MRQ is 0.572. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.572. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.572TTM0.5720.000
TTM0.572YOY0.558+0.014
TTM0.5725Y0.560+0.011
5Y0.56010Y0.589-0.029
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5720.448+0.124
TTM0.5720.450+0.122
YOY0.5580.456+0.102
5Y0.5600.479+0.081
10Y0.5890.496+0.093
1.4.2. Debt to Equity Ratio

Measures if Astec LifeSciences Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Astec LifeSciences Limited to the Agricultural Inputs industry mean.
  • A Debt to Equity ratio of 133.5% means that company has ₹1.34 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Astec LifeSciences Limited:

  • The MRQ is 1.335. The company is able to pay all its debts with equity. +1
  • The TTM is 1.335. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.335TTM1.3350.000
TTM1.335YOY1.261+0.074
TTM1.3355Y1.276+0.059
5Y1.27610Y1.460-0.184
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3350.799+0.536
TTM1.3350.810+0.525
YOY1.2610.872+0.389
5Y1.2760.967+0.309
10Y1.4601.065+0.395

2. Market Valuation of Astec LifeSciences Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Astec LifeSciences Limited generates.

  • Above 15 is considered overpriced but always compare Astec LifeSciences Limited to the Agricultural Inputs industry mean.
  • A PE ratio of 106.23 means the investor is paying ₹106.23 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Astec LifeSciences Limited:

  • The EOD is 95.400. Based on the earnings, the company is expensive. -2
  • The MRQ is 106.234. Based on the earnings, the company is expensive. -2
  • The TTM is 106.234. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD95.400MRQ106.234-10.834
MRQ106.234TTM106.2340.000
TTM106.234YOY38.304+67.931
TTM106.2345Y44.070+62.165
5Y44.07010Y42.088+1.981
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD95.4008.054+87.346
MRQ106.2349.200+97.034
TTM106.23410.599+95.635
YOY38.30411.668+26.636
5Y44.07015.306+28.764
10Y42.08820.446+21.642
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Astec LifeSciences Limited:

  • The EOD is -57.247. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -63.748. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -63.748. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-57.247MRQ-63.748+6.501
MRQ-63.748TTM-63.7480.000
TTM-63.748YOY-42.824-20.925
TTM-63.7485Y-29.263-34.486
5Y-29.26310Y-93.864+64.601
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD-57.2470.371-57.618
MRQ-63.7480.372-64.120
TTM-63.7480.005-63.753
YOY-42.8240.786-43.610
5Y-29.2630.582-29.845
10Y-93.8640.142-94.006
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Astec LifeSciences Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Agricultural Inputs industry mean).
  • A PB ratio of 6.47 means the investor is paying ₹6.47 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Astec LifeSciences Limited:

  • The EOD is 5.813. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.473. Based on the equity, the company is overpriced. -1
  • The TTM is 6.473. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.813MRQ6.473-0.660
MRQ6.473TTM6.4730.000
TTM6.473YOY8.677-2.204
TTM6.4735Y5.960+0.513
5Y5.96010Y5.116+0.845
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD5.8131.403+4.410
MRQ6.4731.559+4.914
TTM6.4731.666+4.807
YOY8.6772.402+6.275
5Y5.9601.954+4.006
10Y5.1162.656+2.460
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Astec LifeSciences Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--11.67611.6760%44.541-74%25.460-54%15.997-27%
Book Value Per Share--213.958213.9580%202.282+6%160.662+33%114.701+87%
Current Ratio--0.9480.9480%1.051-10%1.013-6%1.027-8%
Debt To Asset Ratio--0.5720.5720%0.558+3%0.560+2%0.589-3%
Debt To Equity Ratio--1.3351.3350%1.261+6%1.276+5%1.460-9%
Dividend Per Share--1.5001.5000%1.498+0%1.620-7%1.510-1%
Eps--13.03713.0370%45.825-72%26.898-52%17.653-26%
Free Cash Flow Per Share---21.726-21.7260%-40.988+89%-15.096-31%-8.708-60%
Free Cash Flow To Equity Per Share---2.465-2.4650%0.053-4778%-0.598-76%-0.333-87%
Gross Profit Margin--0.7060.7060%0.879-20%0.853-17%0.910-22%
Intrinsic Value_10Y_max---149.840--------
Intrinsic Value_10Y_min---1333.781--------
Intrinsic Value_1Y_max---10.091--------
Intrinsic Value_1Y_min---64.053--------
Intrinsic Value_3Y_max---34.071--------
Intrinsic Value_3Y_min---253.877--------
Intrinsic Value_5Y_max---62.577--------
Intrinsic Value_5Y_min---509.563--------
Market Cap24388942500.000-11%27158742000.00027158742000.0000%34419048300.000-21%19885297536.000+37%13013939718.000+109%
Net Profit Margin--0.0410.0410%0.133-69%0.093-56%0.065-37%
Operating Margin--0.0890.0890%0.190-53%0.151-41%0.122-27%
Operating Ratio--0.9320.9320%0.822+13%0.860+8%0.867+8%
Pb Ratio5.813-11%6.4736.4730%8.677-25%5.960+9%5.116+27%
Pe Ratio95.400-11%106.234106.2340%38.304+177%44.070+141%42.088+152%
Price Per Share1243.750-11%1385.0001385.0000%1755.250-21%1014.080+37%663.665+109%
Price To Free Cash Flow Ratio-57.247+10%-63.748-63.7480%-42.824-33%-29.263-54%-93.864+47%
Price To Total Gains Ratio94.395-11%105.115105.1150%38.125+176%43.666+141%29.404+257%
Quick Ratio--0.3040.3040%0.676-55%0.595-49%0.567-46%
Return On Assets--0.0260.0260%0.100-74%0.077-66%0.054-52%
Return On Equity--0.0610.0610%0.227-73%0.173-65%0.123-51%
Total Gains Per Share--13.17613.1760%46.039-71%27.080-51%17.506-25%
Usd Book Value--50346624.00050346624.0000%47599032.000+6%37805385.600+33%26990284.520+87%
Usd Book Value Change Per Share--0.1400.1400%0.534-74%0.306-54%0.192-27%
Usd Book Value Per Share--2.5682.5680%2.427+6%1.928+33%1.376+87%
Usd Dividend Per Share--0.0180.0180%0.018+0%0.019-7%0.018-1%
Usd Eps--0.1560.1560%0.550-72%0.323-52%0.212-26%
Usd Free Cash Flow---5112360.000-5112360.0000%-9644904.000+89%-3552254.400-31%-2049175.914-60%
Usd Free Cash Flow Per Share---0.261-0.2610%-0.492+89%-0.181-31%-0.105-60%
Usd Free Cash Flow To Equity Per Share---0.030-0.0300%0.001-4778%-0.007-76%-0.004-87%
Usd Market Cap292667310.000-11%325904904.000325904904.0000%413028579.600-21%238623570.432+37%156167276.616+109%
Usd Price Per Share14.925-11%16.62016.6200%21.063-21%12.169+37%7.964+109%
Usd Profit--3067788.0003067788.0000%10783032.000-72%6329287.200-52%3864350.033-21%
Usd Revenue--75379944.00075379944.0000%81187932.000-7%67514680.800+12%50470133.290+49%
Usd Total Gains Per Share--0.1580.1580%0.552-71%0.325-51%0.210-25%
 EOD+3 -5MRQTTM+0 -0YOY+12 -245Y+9 -2710Y+10 -26

3.2. Fundamental Score

Let's check the fundamental score of Astec LifeSciences Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1595.400
Price to Book Ratio (EOD)Between0-15.813
Net Profit Margin (MRQ)Greater than00.041
Operating Margin (MRQ)Greater than00.089
Quick Ratio (MRQ)Greater than10.304
Current Ratio (MRQ)Greater than10.948
Debt to Asset Ratio (MRQ)Less than10.572
Debt to Equity Ratio (MRQ)Less than11.335
Return on Equity (MRQ)Greater than0.150.061
Return on Assets (MRQ)Greater than0.050.026
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Astec LifeSciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.307
Ma 20Greater thanMa 501,204.318
Ma 50Greater thanMa 1001,059.074
Ma 100Greater thanMa 2001,063.304
OpenGreater thanClose1,246.850
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets9,794,142
Total Liabilities5,598,590
Total Stockholder Equity4,193,632
 As reported
Total Liabilities 5,598,590
Total Stockholder Equity+ 4,193,632
Total Assets = 9,794,142

Assets

Total Assets9,794,142
Total Current Assets4,988,525
Long-term Assets4,805,617
Total Current Assets
Cash And Cash Equivalents 4,734
Short-term Investments 22,801
Net Receivables 1,549,207
Inventory 2,948,477
Other Current Assets 463,306
Total Current Assets  (as reported)4,988,525
Total Current Assets  (calculated)4,988,525
+/-0
Long-term Assets
Property Plant Equipment 4,291,718
Intangible Assets 159,039
Other Assets 211,820
Long-term Assets  (as reported)4,805,617
Long-term Assets  (calculated)4,662,577
+/- 143,040

Liabilities & Shareholders' Equity

Total Current Liabilities5,261,994
Long-term Liabilities336,596
Total Stockholder Equity4,193,632
Total Current Liabilities
Short-term Debt 3,303,176
Short Long Term Debt 3,303,176
Accounts payable 1,771,845
Other Current Liabilities 36,190
Total Current Liabilities  (as reported)5,261,994
Total Current Liabilities  (calculated)8,414,387
+/- 3,152,393
Long-term Liabilities
Long term Debt Total 108,625
Long term Debt 108,625
Long-term Liabilities Other 13,493
Long-term Liabilities  (as reported)336,596
Long-term Liabilities  (calculated)230,743
+/- 105,853
Total Stockholder Equity
Common Stock196,057
Retained Earnings 3,261,459
Accumulated Other Comprehensive Income 132,267
Capital Surplus 607,356
Total Stockholder Equity (as reported)4,193,632
Total Stockholder Equity (calculated)4,197,139
+/- 3,507
Other
Capital Stock196,057
Cash And Equivalents16,844
Cash and Short Term Investments 27,535
Common Stock Shares Outstanding 19,607
Current Deferred Revenue150,783
Liabilities and Stockholders Equity 9,792,222
Net Debt 3,407,067
Net Invested Capital 7,605,433
Net Working Capital -273,469
Property Plant and Equipment Gross 4,291,718
Short Long Term Debt Total 3,411,801



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-31
> Total Assets 
785,374
976,235
1,537,210
1,791,643
2,314,354
2,610,807
2,849,444
3,631,018
3,714,092
3,335,901
4,131,837
4,610,821
5,717,184
6,775,859
8,967,567
9,794,142
9,794,1428,967,5676,775,8595,717,1844,610,8214,131,8373,335,9013,714,0923,631,0182,849,4442,610,8072,314,3541,791,6431,537,210976,235785,374
   > Total Current Assets 
440,390
632,314
763,339
895,974
1,083,165
1,185,662
1,348,978
1,984,365
1,962,178
1,983,730
2,316,791
2,484,776
3,317,512
3,304,304
5,156,772
4,988,525
4,988,5255,156,7723,304,3043,317,5122,484,7762,316,7911,983,7301,962,1781,984,3651,348,9781,185,6621,083,165895,974763,339632,314440,390
       Cash And Cash Equivalents 
15,697
10,873
18,519
30,601
41,064
51,419
44,724
120,200
60,482
28,432
3,312
2,123
3,081
3,388
5,545
4,734
4,7345,5453,3883,0812,1233,31228,43260,482120,20044,72451,41941,06430,60118,51910,87315,697
       Short-term Investments 
0
0
0
0
118,082
243
685
917
10
19,487
5,804
2,465
20,191
12,029
27,896
22,801
22,80127,89612,02920,1912,4655,80419,48710917685243118,0820000
       Net Receivables 
0
0
0
0
0
0
526,166
1,045,185
806,143
1,113,040
1,237,759
1,551,542
2,082,406
2,227,859
3,253,865
1,549,207
1,549,2073,253,8652,227,8592,082,4061,551,5421,237,7591,113,040806,1431,045,185526,166000000
       Inventory 
188,344
290,565
332,532
368,471
503,847
506,563
765,884
719,294
644,627
655,514
784,783
928,495
1,211,706
1,060,915
1,869,464
2,948,477
2,948,4771,869,4641,060,9151,211,706928,495784,783655,514644,627719,294765,884506,563503,847368,471332,532290,565188,344
       Other Current Assets 
236,350
330,876
412,289
496,902
420,172
627,436
537,685
1,143,954
1,257,059
1,280,297
1,522,892
151
128
113
2
463,306
463,30621131281511,522,8921,280,2971,257,0591,143,954537,685627,436420,172496,902412,289330,876236,350
   > Long-term Assets 
344,984
343,921
773,871
895,669
1,231,190
1,425,145
1,500,466
1,646,653
1,751,914
1,352,171
1,815,046
2,126,045
2,399,672
3,471,555
3,810,795
4,805,617
4,805,6173,810,7953,471,5552,399,6722,126,0451,815,0461,352,1711,751,9141,646,6531,500,4661,425,1451,231,190895,669773,871343,921344,984
       Property Plant Equipment 
335,024
329,876
514,504
815,057
1,196,373
1,336,604
1,363,941
1,400,745
1,417,736
1,069,863
1,540,811
1,835,094
2,141,679
3,232,256
3,513,790
4,291,718
4,291,7183,513,7903,232,2562,141,6791,835,0941,540,8111,069,8631,417,7361,400,7451,363,9411,336,6041,196,373815,057514,504329,876335,024
       Long Term Investments 
0
0
0
0
0
0
148
238
53
53
53
53
0
0
0
0
000053535353238148000000
       Intangible Assets 
0
0
0
0
0
0
15,819
85,504
32,970
35,091
28,588
24,144
35,638
51,627
113,904
159,039
159,039113,90451,62735,63824,14428,58835,09132,97085,50415,819000000
       Long-term Assets Other 
9,961
14,045
259,367
80,611
152,781
87,991
132,263
246,588
334,096
220,662
251,398
54
116,513
1
129,815
211,820
211,820129,8151116,51354251,398220,662334,096246,588132,26387,991152,78180,611259,36714,0459,961
> Total Liabilities 
555,620
650,985
606,126
821,397
1,327,291
1,552,094
1,714,099
2,277,145
2,544,713
1,954,179
2,432,496
2,582,831
3,248,241
3,682,686
5,000,981
5,598,590
5,598,5905,000,9813,682,6863,248,2412,582,8312,432,4961,954,1792,544,7132,277,1451,714,0991,552,0941,327,291821,397606,126650,985555,620
   > Total Current Liabilities 
211,636
197,085
221,668
361,305
964,731
1,023,145
1,163,286
1,787,754
2,092,487
1,937,229
2,383,878
2,488,043
3,183,629
3,222,765
4,905,881
5,261,994
5,261,9944,905,8813,222,7653,183,6292,488,0432,383,8781,937,2292,092,4871,787,7541,163,2861,023,145964,731361,305221,668197,085211,636
       Short-term Debt 
0
0
0
0
591,504
471,459
575,850
773,846
1,081,943
1,259,988
1,243,260
1,756,679
987,115
1,471,991
2,793,731
3,303,176
3,303,1762,793,7311,471,991987,1151,756,6791,243,2601,259,9881,081,943773,846575,850471,459591,5040000
       Short Long Term Debt 
0
0
0
0
0
0
827,784
28,739
101,992
1,259,988
1,243,260
1,756,679
987,115
1,470,310
2,793,731
3,303,176
3,303,1762,793,7311,470,310987,1151,756,6791,243,2601,259,988101,99228,739827,784000000
       Accounts payable 
154,197
153,774
145,203
228,604
309,805
460,872
456,472
838,335
758,673
570,706
999,300
632,544
2,023,896
1,248,149
1,898,276
1,771,845
1,771,8451,898,2761,248,1492,023,896632,544999,300570,706758,673838,335456,472460,872309,805228,604145,203153,774154,197
       Other Current Liabilities 
57,439
43,311
76,465
132,701
63,421
90,815
130,964
175,573
251,871
106,535
141,318
3,165
1
69
41
36,190
36,190416913,165141,318106,535251,871175,573130,96490,81563,421132,70176,46543,31157,439
   > Long-term Liabilities 
343,984
453,899
384,458
460,093
362,560
528,949
550,813
489,391
452,227
16,950
48,618
94,788
64,612
459,921
95,100
336,596
336,59695,100459,92164,61294,78848,61816,950452,227489,391550,813528,949362,560460,093384,458453,899343,984
       Long term Debt Total 
0
0
0
0
0
0
0
0
81,770
4,019
2,488
0
0
400,000
0
108,625
108,6250400,000002,4884,01981,77000000000
       Other Liabilities 
0
0
0
0
0
0
356,266
357,186
4,492
12,931
46,130
94,788
64,612
59,921
174,521
0
0174,52159,92164,61294,78846,13012,9314,492357,186356,266000000
       Deferred Long Term Liability 
0
0
0
0
0
0
599
599
0
0
0
0
0
0
0
0
00000000599599000000
> Total Stockholder Equity
227,515
322,992
928,808
967,964
985,251
1,057,461
1,134,908
1,353,364
1,168,484
1,380,218
1,696,502
2,024,865
2,465,658
3,091,781
3,964,954
4,193,632
4,193,6323,964,9543,091,7812,465,6582,024,8651,696,5021,380,2181,168,4841,353,3641,134,9081,057,461985,251967,964928,808322,992227,515
   Common Stock
94,290
94,290
169,291
169,291
169,291
180,441
185,291
194,551
194,551
195,129
195,277
195,527
195,684
195,876
195,976
196,057
196,057195,976195,876195,684195,527195,277195,129194,551194,551185,291180,441169,291169,291169,29194,29094,290
   Retained Earnings 
76,494
141,933
224,217
253,364
252,181
290,959
351,038
464,494
271,911
476,574
789,464
1,111,051
1,548,978
2,168,350
3,037,504
3,261,459
3,261,4593,037,5042,168,3501,548,9781,111,051789,464476,574271,911464,494351,038290,959252,181253,364224,217141,93376,494
   Accumulated Other Comprehensive Income 
-67,402
-99,879
-141,518
-198,582
-283,835
-400,908
-546,781
-665,847
-759,926
-199,064
-324,403
-508,713
-733,172
129,241
128,631
132,267
132,267128,631129,241-733,172-508,713-324,403-199,064-759,926-665,847-546,781-400,908-283,835-198,582-141,518-99,879-67,402
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
580,231
585,500
589,164
598,314
603,480
607,356
607,356603,480598,314589,164585,500580,2310000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
124,133
186,648
676,818
743,891
847,613
986,969
1,145,360
1,360,167
1,461,948
907,579
1,036,164
1,227,000
-1,869,590
598,314
602,843
603,849
603,849602,843598,314-1,869,5901,227,0001,036,164907,5791,461,9481,360,1671,145,360986,969847,613743,891676,818186,648124,133



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue6,281,662
Cost of Revenue-4,012,441
Gross Profit2,269,2212,269,221
 
Operating Income (+$)
Gross Profit2,269,221
Operating Expense-1,843,206
Operating Income434,559426,015
 
Operating Expense (+$)
Research Development14,853
Selling General Administrative122,564
Selling And Marketing Expenses75,102
Operating Expense1,843,206212,519
 
Net Interest Income (+$)
Interest Income207,143
Interest Expense-207,143
Other Finance Cost-207,143
Net Interest Income-207,143
 
Pretax Income (+$)
Operating Income434,559
Net Interest Income-207,143
Other Non-Operating Income Expenses0
Income Before Tax (EBT)349,473519,645
EBIT - interestExpense = 349,473
349,183
462,792
Interest Expense207,143
Earnings Before Interest and Taxes (EBIT)556,616556,616
Earnings Before Interest and Taxes (EBITDA)893,141
 
After tax Income (+$)
Income Before Tax349,473
Tax Provision-93,534
Net Income From Continuing Ops255,940255,939
Net Income255,649
Net Income Applicable To Common Shares255,649
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,855,647
Total Other Income/Expenses Net-85,086207,143
 

Technical Analysis of Astec LifeSciences Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Astec LifeSciences Limited. The general trend of Astec LifeSciences Limited is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Astec LifeSciences Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Astec LifeSciences Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1,290 < 1,297 < 1,303.

The bearish price targets are: 1,225 > 1,135 > 1,042.

Tweet this
Astec LifeSciences Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Astec LifeSciences Limited. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Astec LifeSciences Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Astec LifeSciences Limited. The current macd is 55.82.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Astec LifeSciences Limited price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Astec LifeSciences Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Astec LifeSciences Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Astec LifeSciences Limited Daily Moving Average Convergence/Divergence (MACD) ChartAstec LifeSciences Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Astec LifeSciences Limited. The current adx is 45.96.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Astec LifeSciences Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Astec LifeSciences Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Astec LifeSciences Limited. The current sar is 1,336.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Astec LifeSciences Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Astec LifeSciences Limited. The current rsi is 61.31. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Astec LifeSciences Limited Daily Relative Strength Index (RSI) ChartAstec LifeSciences Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Astec LifeSciences Limited. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Astec LifeSciences Limited price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Astec LifeSciences Limited Daily Stochastic Oscillator ChartAstec LifeSciences Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Astec LifeSciences Limited. The current cci is 44.56.

Astec LifeSciences Limited Daily Commodity Channel Index (CCI) ChartAstec LifeSciences Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Astec LifeSciences Limited. The current cmo is 15.12.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Astec LifeSciences Limited Daily Chande Momentum Oscillator (CMO) ChartAstec LifeSciences Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Astec LifeSciences Limited. The current willr is -43.4833844.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Astec LifeSciences Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Astec LifeSciences Limited Daily Williams %R ChartAstec LifeSciences Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Astec LifeSciences Limited.

Astec LifeSciences Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Astec LifeSciences Limited. The current atr is 52.82.

Astec LifeSciences Limited Daily Average True Range (ATR) ChartAstec LifeSciences Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Astec LifeSciences Limited. The current obv is 2,772,288.

Astec LifeSciences Limited Daily On-Balance Volume (OBV) ChartAstec LifeSciences Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Astec LifeSciences Limited. The current mfi is 86.46.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Astec LifeSciences Limited Daily Money Flow Index (MFI) ChartAstec LifeSciences Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Astec LifeSciences Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

Astec LifeSciences Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Astec LifeSciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.307
Ma 20Greater thanMa 501,204.318
Ma 50Greater thanMa 1001,059.074
Ma 100Greater thanMa 2001,063.304
OpenGreater thanClose1,246.850
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Astec LifeSciences Limited with someone you think should read this too:
  • Are you bullish or bearish on Astec LifeSciences Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Astec LifeSciences Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Astec LifeSciences Limited

I send you an email if I find something interesting about Astec LifeSciences Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Astec LifeSciences Limited.

Receive notifications about Astec LifeSciences Limited in your mailbox!